Episode Details

Back to Episodes

Extramedullary disease in multiple myeloma: biology, management strategies, & the RedirecTT-1 trial

Episode 304 Published 1 year, 1 month ago
Description

In this episode of the VJHemOnc Podcast, we dive into one of the more aggressive and challenging manifestations of multiple myeloma, extramedullary disease (EMD). We are joined by experts Meral Beksac, MD, Istinye University Ankara Liv Hospital, Ankara, Turkey, Mehmet Samur, PhD, Dana-Farber Cancer Institute, Boston, MA, Saurabh Zanwar, MD, MBBS, Mayo Clinic, Rochester, MN, and Shaji Kumar, MD, Mayo Clinic, Rochester, MN. They discuss the latest insights on how EMD presents, how it’s managed, and what we’re learning about its complex biology. Plus, we’ll explore emerging treatment strategies and clinical trials, including the RedirecTT-1 trial (NCT04586426).

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us